Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Global Kidney Exchange.
M. Rees,¹ T. Dunn,¹ S. Rees,¹ J. Rogers,¹ L. Reece,¹ A. Roth,² C. Kuhr,¹ O. Ekwenna,¹ D. Fumo,¹ K. Krawiec,³ S. Jain,¹ C. Marsh,¹ M. Tan,¹ S. Paloyo.⁴
¹Alliance for Paired Kidney Donation, Perrysburg; ²Stanford University, Palo Alto; ³Duke University, Durham; ⁴Philippine General Hospital, Manila, Philippines.
Introduction: Instead of thinking of the developing world as a place where there are desperate people who will sell their kidneys for money, we propose…
2016 American Transplant Congress
Regression of Asymptomatic Cardiomyopathy and Clinical Outcome of Renal Transplant Recipients: Long-Term Extension of Two Randomized Controlled Trials.
E. Paoletti, D. Bellino, L. Marsano, R. Russo, F. Masarino, G. Garibotto.
Nephrology, Dialysis, and Transplantation, University of Genoa, Genoa, Italy.
Background Asymptomatic left ventricular hypertrophy (LVH) is highly prevalent and associated with adverse outcome in renal transplant recipients (RTRs). Nonetheless, there are currently no available…
2016 American Transplant Congress
Resveratrol Effectively Suppress Th17 Associated Allo-Immune Responses by the Modulation of AMPK/mTOR Pathway.
B. Chung, K. Doh, J.-W. Min, K. Kim, B.-M. Kim, M.-L. Cho, C. Yang.
Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
The aim of this study is to investigate the effect of resveratrol on Th17 allo-immune responses under tacrolimus (Tac)-based immune suppression. First, we investigated the…
2016 American Transplant Congress
Live Kidney Donors Have Significant Out-of-Pocket Costs Associated with Donation.
J. Moore, J. Leanza, A. Massie, N. Dagher, D. Segev.
Johns Hopkins School of Medicine, Baltimore.
While financial barriers to transplantation have been recognized, limited data exists on the total non-reimbursed expense associated with live donation. Furthermore, donor costs have not…
2016 American Transplant Congress
Recipient Age and KDPI Are Potent Predictors of Early Acute Rejection in the Modern Era of Deceased Donor Kidney Transplantation.
D. Keith, G. Vranic, A. Nishio Lucar.
Medicine, University of Virginia, Charlottesville, VA.
The rate of acute rejection in the first six months after deceased donor (DD) kidney transplant is about 10% in the modern era of immunosuppression.…
2016 American Transplant Congress
Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.
D. Zecher,¹ A. Cumpelik,² B. Ruhland,¹ B. Banas,¹ H. Hopfer,³ M. Dickenmann,⁴ J. Schifferli.²
¹Nephrology, Regensburg University Hospital, Regensburg, Germany; ²Biomedicine, Basel University Hospital, Basel, Switzerland; ³Pathology, Basel University Hospital, Basel, Switzerland; ⁴Nephrology, Basel University Hospital, Basel, Switzerland.
Background: The release of surface-derived microvesicles (MV) is a common phenomenon of cellular activation and occurs specifically as a consequence of terminal complement complex assembly…
2016 American Transplant Congress
Early Onset Hyperuricemia Is a Prognostic Marker for Kidney Allograft Dysfunction.
M. Han,¹ S. Yang,² I. Jung,³ S.-K. Park,⁴ Y. Kim,⁵ D. Han,⁵ Y. Kim,¹ S. Kim,⁶ J. Lee.⁷
¹Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; ²Kidney Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; ³Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; ⁴Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁵Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; ⁶Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; ⁷Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Aim: It is not certain whether hyperuricemia is a true risk factor of kidney allograft failure. We investigated the association of hyperuricemia and graft outcome.Methods:…
2016 American Transplant Congress
Impact of Pre-Existing Comorbidities on Long-Term Patient and Graft Survival in Kidney Transplant Recipients.
F. Halleck, D. Khadzhynov, L. Lehner, E. Schrezenmeier, M. Duerr, A. Kleinsteuber, K. Budde, O. Staeck.
Nephrology, Charité University, Berlin, Germany.
BACKGROUND Outcomes of patients with end-stage renal disease are largely affected by their comorbidities. Detailed data evaluating the impact of pre-transplant comorbidities on the long-term…
2016 American Transplant Congress
Kidney Transplant Patient Preferences and Trade-Offs for Outcomes After Transplantation.
M. Howell,^1,2 G. Wong,^1,2,3 J. Rose,⁴ A. Tong,^1,2 J. Craig,^1,2 K. Howard.²
¹Centre for Kidney Research, The Childrens Hospital at Westmead, Westmead, NSW, Australia; ²School of Public Health, University of Sydney, Sydney, NSW, Australia; ³Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia; ⁴Institute of Choice, University of South Australia, North Sydney, NSW, Australia.
Aim: To evaluate preferences and trade-offs patients may accept to avoid adverse outcomes of long-term immunosuppression. Background: Patient preferences in clinical decisions are increasingly relevant,…
2016 American Transplant Congress
Rurality Status Does Not Affect Kidney Transplant (KTP) Rates Among Veterans Compared to Medicare, Medicaid, and Private Insurance (PrivIns) Beneficiaries.
R. Kalil,^1,2 C. Franciscus,² A. O'Shea.^1,2
¹Internal Medicine/Nephrology, University of Iowa, Iowa City; ²Comprehensive Access and Delivery Research Evaluation (CADRE), Iowa City VAMC, Iowa City.
Background: A larger proportion of Veterans live in rural areas compared to non-Veterans. It is unknown whether rural status affects KTP rates among Veterans.Methods: Study…